These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22388732)

  • 21. Cisplatin-induced ototoxicity: transporters playing a role in cisplatin toxicity.
    Waissbluth S; Daniel SJ
    Hear Res; 2013 May; 299():37-45. PubMed ID: 23467171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
    Huang X; Whitworth CA; Rybak LP
    Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The protective effect of Ginkgo biloba extract against experimental cisplatin ototoxicity: animal research using distortion product otoacoustic emissions.
    Cakil B; Basar FS; Atmaca S; Cengel SK; Tekat A; Tanyeri Y
    J Laryngol Otol; 2012 Nov; 126(11):1097-101. PubMed ID: 22975015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genetic background of cisplatin induced ototoxicity].
    Jurajda M; Talach T; Kostřica R; Lakomý R; Kocák I; Cvanová M
    Klin Onkol; 2012; 25(3):184-7. PubMed ID: 22724567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of antioxidants and other agents to prevent cisplatin ototoxicity.
    Rybak LP; Whitworth C; Somani S
    Laryngoscope; 1999 Nov; 109(11):1740-4. PubMed ID: 10569399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisplatin ototoxicity.
    Malhotra H
    Indian J Cancer; 2009; 46(4):262-3. PubMed ID: 19749455
    [No Abstract]   [Full Text] [Related]  

  • 27. Cisplatin-induced metabolome changes in serum: an experimental approach to identify markers for ototoxicity.
    Videhult Pierre P; Haglöf J; Linder B; Engskog MKR; Arvidsson T; Pettersson C; Fransson A; Laurell G
    Acta Otolaryngol; 2017 Oct; 137(10):1024-1030. PubMed ID: 28537102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
    Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
    Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss.
    Dhukhwa A; Al Aameri RFH; Sheth S; Mukherjea D; Rybak L; Ramkumar V
    Sci Rep; 2021 Apr; 11(1):8116. PubMed ID: 33854102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection against cisplatin ototoxicity by adenosine agonists.
    Whitworth CA; Ramkumar V; Jones B; Tsukasaki N; Rybak LP
    Biochem Pharmacol; 2004 May; 67(9):1801-7. PubMed ID: 15081879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotinamide adenine dinucleotide: An essential factor in preserving hearing in cisplatin-induced ototoxicity.
    Kim HJ; Oh GS; Shen A; Lee SB; Khadka D; Pandit A; Shim H; Yang SH; Cho EY; Song J; Kwak TH; Choe SK; Park R; So HS
    Hear Res; 2015 Aug; 326():30-9. PubMed ID: 25891352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SOD2 genetic variant associated with treatment-related ototoxicity in cisplatin-treated pediatric medulloblastoma.
    Brown AL; Lupo PJ; Okcu MF; Lau CC; Rednam S; Scheurer ME
    Cancer Med; 2015 Nov; 4(11):1679-86. PubMed ID: 26400460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further Investigation of the Role of
    Drögemöller BI; Brooks B; Critchley C; Monzon JG; Wright GEB; Liu G; Renouf DJ; Kollmannsberger CK; Bedard PL; Hayden MR; Gelmon KA; Carleton BC; Ross CJD
    Clin Cancer Res; 2018 Apr; 24(8):1866-1871. PubMed ID: 29358504
    [No Abstract]   [Full Text] [Related]  

  • 34. Minocycline attenuates ototoxicity and enhances antitumor activity of cisplatin treatment in vitro.
    Du B; Zhang Y; Tang Y; Wang P
    Otolaryngol Head Neck Surg; 2011 May; 144(5):719-25. PubMed ID: 21493367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel synthetic protective compound, KR-22335, against cisplatin-induced auditory cell death.
    Shin YS; Song SJ; Kang S; Hwang HS; Jung YS; Kim CH
    J Appl Toxicol; 2014 Feb; 34(2):191-204. PubMed ID: 23297007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The transduction of neurotrophin-3/GDNF attenuates the SGNC damage in deaf mice].
    Chen XW; Li H; Cao KL; Wei CG; Jin X
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1517-20. PubMed ID: 14521734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of platinum-induced ototoxicity in pediatric patients in Quebec.
    Peleva E; Emami N; Alzahrani M; Bezdjian A; Gurberg J; Carret AS; Daniel SJ
    Pediatr Blood Cancer; 2014 Nov; 61(11):2012-7. PubMed ID: 24976616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of cisplatin ototoxicity: theoretical review.
    Gonçalves MS; Silveira AF; Teixeira AR; Hyppolito MA
    J Laryngol Otol; 2013 Jun; 127(6):536-41. PubMed ID: 23651576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ototoxicity of chemotherapeutic agents.
    Schweitzer VG
    Otolaryngol Clin North Am; 1993 Oct; 26(5):759-89. PubMed ID: 8233488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin.
    Lanvers-Kaminsky C; Ciarimboli G
    Pharmacogenomics; 2017 Dec; 18(18):1683-1695. PubMed ID: 29173064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.